Addex Therapeutics
ADXN----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Addex Therapeutics(ADXN) the Revenue is 12.32 K (-72.91%);the EBIT is -799.38 K (+12.77%);the EPS is -1.49 (+45.91%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B72.91%
----
----
EBIT
-0.00B12.77%
----
----
EPS
-1.486445.91%
----
----
Upcoming earnings report - Q3 FY2026
Available dateNov 9, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf